Galderma S.A., a leading global dermatology company headquartered in Switzerland (CH), has been at the forefront of skin health since its establishment in 1981. With a strong presence in major operational regions including Europe, North America, and Asia, Galderma focuses on innovative solutions in dermatology, offering a diverse portfolio that encompasses prescription products, aesthetic treatments, and consumer skin care. Renowned for its flagship brands such as Restylane and Cetaphil, Galderma distinguishes itself through a commitment to scientific research and development, ensuring high-quality, effective products tailored to various skin concerns. The company has achieved significant milestones, including numerous regulatory approvals and a robust market position, making it a trusted name in the dermatological field. With a dedication to enhancing skin health, Galderma continues to lead advancements in dermatological care worldwide.
How does Galderma S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Galderma S.A.'s score of 40 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Galderma S.A., headquartered in Switzerland (CH), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Galderma Group AG, which may influence its climate-related initiatives and commitments. Despite the lack of direct emissions data, Galderma S.A. is part of a broader corporate family that may have established climate commitments. However, no specific reduction targets or initiatives have been documented for Galderma S.A. at this time. The absence of data suggests that the company may still be in the process of developing its climate strategy or reporting framework. As a subsidiary, Galderma S.A. may align its environmental goals with those of its parent company, Galderma Group AG, but specific details on emissions reduction targets or climate pledges are not available. The company’s commitment to sustainability and climate action remains unclear without concrete data or defined initiatives.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 9,800,000 | 0,000,000 |
| Scope 2 | 4,200,000 | 000,000 |
| Scope 3 | - | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Galderma S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

